Prof Emmanuel Barranger is an expert in Oncology at Centre Antoine Lacassagne (France). As of May 2026, ScienceLeadR ranks Emmanuel Barranger in the top 1% of experts worldwide for Breast Neoplasms and Breast Diseases. Emmanuel Barranger has authored 324 publications, the most recent in 2026, and is an investigator in 4 clinical trials. SLR score: 916 (community average: 125). How the SLR is computed.

LeadR Profile

Prof Emmanuel Barranger Centre Antoine Lacassagne France
916 ScienceLeadR Reputation 916
Network Map

Oncology

Subspecialties: Gynecology - Obstetrics - Surgery

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2002 - 2026

Source: PubMed

Centre Antoine Lacassagne

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 324

Citations

Citations: 6 343 1st author: 58 Last author: 109 Unique author: 14


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Hyperbaric Oxygen Therapy after reconstructive breast surgery: A retrospective study.
PMID 42106115 — retrospective studies, nipples, breast, hyperbaric oxygenation, therapeutics
J Gynecol Obstet Hum Reprod20260
Radical vulvectomy with profunda artery perforator flap reconstruction.
PMID 41946647 — perforator flap, genital neoplasms, female, arteries, vulvectomy
Int J Gynecol Cancer20260
Iodine 125 grain isotope detection compared to standard metal guide detection for breast cancers: The IODINE BREAST, a randomised, non-inferiority trial.
PMID 41477927 — breast neoplasms, pain, seeds, breast, edible grain
Eur J Surg Oncol20250
Surgical approach and maintenance therapy in advanced low-grade serous ovarian cancer: Insights from the French ESME database.
PMID 41411701 — progression-free survival, ovary, genital neoplasms, female, neoplasms, bevacizumab, maintenance, ovarian neoplasms, therapeutics
Int J Gynecol Cancer20250
Therapeutic impact of eras protocol implementation in cytoreductive surgery for ovarian cancer.
PMID 40812190 — reproduction, cytoreduction surgical procedures, ovary, neoplasms, obstetrics, recycling, ovarian neoplasms, gynecology, therapeutics
Eur J Obstet Gynecol Reprod Biol20253

Clinical Studies 4

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 3
Phase 4 1

By status:

Completed 4

By type:

Interventional 4

By Monocentric/Multicentric:

monocentric 4
multicentric2to4 0
multicentric5to9 0
multicentricup10 0

Main Topics

LeadR Networks

Main global connection map